Outcomes4Me Secures $21M in Funding Learn more >>

Patient Login
Patient Sign Up
Log out
Go to Patient Dashboard
Go to Dashboard
Patient Login
Patient Sign Up
Log out
Go to Patient Dashboard
Go to Dashboard

Learn | Resources to take control of your cancer

Explore articles on personalized treatment options, clinical trials,
and symptom management to empower every step of your journey.
doctor looking into microscope in a lab

Understanding HER2-low and HER2-0 breast cancer: Insights from new research

Recent advancements have brought attention to a specific group of breast cancers called “HER2-low.” These...
doctor consulting older woman

Understanding side effects caused by HER2+ breast cancer treatment

Safety outcomes with first-line treatment of Enhertu (fam-trastuzumab deruxtecan-nxki; T-DXd) plus Perjeta (pertuzumab) is comparable...
DNA test concept, genetic profiling background

ASCO 2025: Enhertu remains efficacious regardless of mutation status in HER2-low, ultra-low metastatic breast cancer

Enhertu (fam-trastuzumab deruxtecan-nxki or T-DXd) has shown promising results in slowing down or stopping the...
older woman looking at tablet at home

ASCO 2025: A glimpse into the future of breast cancer care

The American Society of Clinical Oncology (ASCO) Annual Meeting, held in Chicago from May 30...
A scientist placing a slide under a microscope close up

ASCO 2025: Re-evaluating HER2 levels in ER-positive breast cancer

A recent study is aiming to understand and classify the HER2 protein levels in breast...
doctor researchers working together in medical lab

ASCO 2025: Using artificial intelligence in HER2-low breast cancer pathology

One of the most important first steps after receiving a breast cancer diagnosis is understanding...